Bordetella bronchiseptica (CCUG 2514, NRRL B-140, DSM 10303)

Name: Bordetella bronchiseptica (CCUG 2514, NRRL B-140, DSM 10303)
Creator: BacDive
License: http://creativecommons.org/licenses/by/4.0/

BacDive ID 375

Type strain

Strain Designation B-140

Culture col. no. CCUG 2514 NRRL B-140 DSM 10303 ATCC 4617 NCIB 9935 6 more

NCBI tax ID(s) 518

Special Collections DSMZ CCUG CIP

History <- ATCC; ATCC 4617 <- NRRL; B-140 <- W. A. Hagan; (Brucella bronchiseptica) <- F. Breed; CIP <- 1953, ATCC <- K.B. Rapper, NRRL: strain B-140

Links

Bordetella bronchiseptica B-140 is an aerobe, Gram-negative, rod-shaped human pathogen of the family Alcaligenaceae.

Gram-negative rod-shaped aerobe human pathogen genome sequence 16S sequence Bacteria

Name and taxonomic classification

SI-ID 36084

LMG 1808,ATCC 4617,CCUG 2514,NCIB 9935,NCTC 8344,NRRL B-140,NCIMB 9935,CCM 4416,CIP 53.157,CECT 440,CCRC 11548,BCRC 11548,CCT 2741,NCIB 8344,NCAIM B.01747,CDBB 1104,ACM 5043,CNCTC 6262,CGMCC 1.2418,DSM 10303

@ref 20215

Last LPSN update 2026-02-09 11:17:51

Domain Bacteria

Phylum Pseudomonadota

Class Betaproteobacteria

Order Burkholderiales

Family Alcaligenaceae

Genus Bordetella

Species Bordetella bronchiseptica

Full scientific name Bordetella bronchiseptica (Ferry 1912) Moreno-López 1952 (Approved Lists 1980)

Synonyms (1)

"Bacillus bronchisepticus"

BacDive ID	Other strains from **Bordetella bronchiseptica** (58)	Type strain
376	B. bronchiseptica DSM 13414, ATCC 19395, CCUG 219, CIP 55.110, ... (type strain)
134392	B. bronchiseptica R970, 9950, CIP 107603
134393	B. bronchiseptica 10111, R971, CIP 107604
134394	B. bronchiseptica 10035, R972, CIP 107605
135517	B. bronchiseptica 10868, R977, CIP 107601
136001	B. bronchiseptica 277-86, CIP 102314
136677	B. bronchiseptica R973, 10111, CIP 107597
136678	B. bronchiseptica R974, 10302, CIP 107598
136679	B. bronchiseptica R975, 10476, CIP 107599
136680	B. bronchiseptica 10668, R976, CIP 107600
136681	B. bronchiseptica 10970, R978, CIP 107602
137947	B. bronchiseptica I, CIP 52.125
137951	B. bronchiseptica III, CIP 52.126
137956	B. bronchiseptica VI, CIP 52.127
138713	B. bronchiseptica CIP A34
141304	B. bronchiseptica CCUG 791
141340	B. bronchiseptica CCUG 1111
141384	B. bronchiseptica CCUG 1326
141396	B. bronchiseptica CCUG 1422, NCTC 8761
141562	B. bronchiseptica CCUG 3036
141694	B. bronchiseptica CCUG 4878
141859	B. bronchiseptica CCUG 7865
142805	B. bronchiseptica CCUG 15000
142845	B. bronchiseptica CCUG 15270
144042	B. bronchiseptica CCUG 22469
144274	B. bronchiseptica CCUG 24161
145366	B. bronchiseptica CCUG 28279
146486	B. bronchiseptica CCUG 31300, LMG 14526
148746	B. bronchiseptica CCUG 35892
150098	B. bronchiseptica CCUG 38987
150157	B. bronchiseptica CCUG 39136
150293	B. bronchiseptica CCUG 39529
150347	B. bronchiseptica CCUG 39699
150730	B. bronchiseptica CCUG 42109
150891	B. bronchiseptica CCUG 42640
150898	B. bronchiseptica CCUG 42661
151556	B. bronchiseptica CCUG 44311
151656	B. bronchiseptica CCUG 44547
152048	B. bronchiseptica CCUG 45638
152325	B. bronchiseptica CCUG 46445
152486	B. bronchiseptica CCUG 46916
152512	B. bronchiseptica CCUG 46980
152545	B. bronchiseptica CCUG 47033
152591	B. bronchiseptica CCUG 47159
152643	B. bronchiseptica CCUG 47271
152731	B. bronchiseptica CCUG 47499
152785	B. bronchiseptica CCUG 47609
152788	B. bronchiseptica CCUG 47614
153309	B. bronchiseptica CCUG 49062
154441	B. bronchiseptica CCUG 53629
154620	B. bronchiseptica CCUG 54609
154883	B. bronchiseptica CCUG 55529
155211	B. bronchiseptica CCUG 56928
156246	B. bronchiseptica CCUG 60853
171323	B. bronchiseptica ECL, CRBIP4.199, BOR 199
171324	B. bronchiseptica FR3025, CRBIP4.200, BOR 200
171325	B. bronchiseptica CB 43, CRBIP4.201, BOR 201
171326	B. bronchiseptica CB 44, CRBIP4.202, BOR 202

Morphology

Cell morphology

@ref	Gram stain	Cell shape	Confidence
117058	negative	rod-shaped
125439	negative		97.5
125438	negative		96.479

Colony morphology

@ref	Incubation period	Hemolysis ability
3892	1-2 days
117058		1

Culture and growth conditions

Culture medium

@ref	Name	Medium link	Composition
34207	MEDIUM 440 - for Bordetella		Distilled water make up to (1000.000 ml);Glycerol (10.000 ml);Bordet gengou agar (30.000 g);Sheep blood (200.000 ml)
3892	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	Medium recipe at MediaDive	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
3892	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	Medium recipe at MediaDive	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
117058	CIP Medium 440	Medium recipe at CIP

Culture temp

@ref	Growth	Type	Temperature (°C)
3892	positive	growth	37
34207	positive	growth	30
44557	positive	growth	37
117058	positive	growth	15-41
117058	negative	growth	5
117058	negative	growth	45

Physiology and metabolism

Oxygen tolerance

@ref	Oxygen tolerance	Confidence
44557	aerobe
117058	obligate aerobe
125439	obligate aerobe	96.9

Spore formation

@ref	Spore formation	Confidence
125439		96.6

Halophily

@ref	Salt	Growth	Tested relation	Concentration
117058	NaCl	positive	growth	0-6 %
117058	NaCl		growth	8 %
117058	NaCl		growth	10 %

Metabolite utilization

@ref	Chebi-ID	Metabolite	Utilization activity	Kind of utilization tested
68369	17128 ChEBI	adipate	+	assimilation	from API 20NE
68369	29016 ChEBI	arginine	-	hydrolysis	from API 20NE
117058	16947 ChEBI	citrate	+	carbon source
68377	15824 ChEBI	D-fructose	-	builds acid from	from API NH
68377	17634 ChEBI	D-glucose	-	builds acid from	from API NH
68369	17634 ChEBI	D-glucose	-	assimilation	from API 20NE
68369	16899 ChEBI	D-mannitol	-	assimilation	from API 20NE
68369	16024 ChEBI	D-mannose	-	assimilation	from API 20NE
68369	27689 ChEBI	decanoate	-	assimilation	from API 20NE
117058	4853 ChEBI	esculin	-	hydrolysis
68369	4853 ChEBI	esculin	-	hydrolysis	from API 20NE
68369	5291 ChEBI	gelatin	-	hydrolysis	from API 20NE
68369	24265 ChEBI	gluconate	-	assimilation	from API 20NE
117058	606565 ChEBI	hippurate	+	hydrolysis
68369	30849 ChEBI	L-arabinose	-	assimilation	from API 20NE
68369	25115 ChEBI	malate	+	assimilation	from API 20NE
117058	15792 ChEBI	malonate	-	assimilation
68377	17306 ChEBI	maltose	-	builds acid from	from API NH
68369	17306 ChEBI	maltose	-	assimilation	from API 20NE
68369	59640 ChEBI	N-acetylglucosamine	-	assimilation	from API 20NE
117058	17632 ChEBI	nitrate	-	builds gas from
117058	17632 ChEBI	nitrate	+	reduction
117058	17632 ChEBI	nitrate	-	respiration
68369	17632 ChEBI	nitrate	+	reduction	from API 20NE
117058	16301 ChEBI	nitrite	-	builds gas from
117058	16301 ChEBI	nitrite	-	reduction
68377	17992 ChEBI	sucrose	-	builds acid from	from API NH
117058	35020 ChEBI	tributyrin	-	hydrolysis
68377	27897 ChEBI	tryptophan	-	energy source	from API NH
68369	27897 ChEBI	tryptophan	-	energy source	from API 20NE
68369	16199 ChEBI	urea	+	hydrolysis	from API 20NE
68377	16199 ChEBI	urea	+	hydrolysis	from API NH

Antibiotic resistance

@ref	Metabolite	Is sensitive	Is resistant
117058	0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)

Metabolite production

@ref	Chebi-ID	Metabolite
68377	35581 ChEBI	indole	from API NH
68369	35581 ChEBI	indole	from API 20NE
117058	35581 ChEBI	indole

Metabolite tests

@ref	Chebi-ID	Metabolite	Indole test	Voges-proskauer-test	Methylred-test
117058	15688 ChEBI	acetoin		-
117058	17234 ChEBI	glucose			-
68377	35581 ChEBI	indole	-			from API NH
68369	35581 ChEBI	indole	-			from API 20NE

Enzymes

@ref	Value	Activity	Ec
68382	acid phosphatase	+	3.1.3.2	from API zym
117058	alcohol dehydrogenase	-	1.1.1.1
68382	alkaline phosphatase	+	3.1.3.1	from API zym
68377	alkaline phosphatase	-	3.1.3.1	from API NH
68382	alpha-chymotrypsin	-	3.4.21.1	from API zym
68382	alpha-fucosidase	-	3.2.1.51	from API zym
68382	alpha-galactosidase	-	3.2.1.22	from API zym
68382	alpha-glucosidase	-	3.2.1.20	from API zym
68382	alpha-mannosidase	-	3.2.1.24	from API zym
117058	amylase	-
68369	arginine dihydrolase	-	3.5.3.6	from API 20NE
68382	beta-galactosidase	-	3.2.1.23	from API zym
117058	beta-galactosidase	-	3.2.1.23
68377	beta-galactosidase	-	3.2.1.23	from API NH
68382	beta-glucosidase	-	3.2.1.21	from API zym
68369	beta-glucosidase	-	3.2.1.21	from API 20NE
68382	beta-glucuronidase	-	3.2.1.31	from API zym
68377	beta-lactamase	-	3.5.2.6	from API NH
117058	caseinase	-	3.4.21.50
3892	catalase	+	1.11.1.6
117058	catalase	+	1.11.1.6
68382	cystine arylamidase	-	3.4.11.3	from API zym
68369	cytochrome oxidase	+	1.9.3.1	from API 20NE
3892	cytochrome-c oxidase	+	1.9.3.1
117058	DNase	-
68382	esterase (C 4)	+		from API zym
68382	esterase lipase (C 8)	-		from API zym
117058	gamma-glutamyltransferase	+	2.3.2.2
117058	gelatinase	-
68369	gelatinase	-		from API 20NE
117058	lecithinase	-
68382	leucine arylamidase	+	3.4.11.1	from API zym
117058	lipase	-
68382	lipase (C 14)	-		from API zym
117058	lysine decarboxylase	-	4.1.1.18
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52	from API zym
68382	naphthol-AS-BI-phosphohydrolase	-		from API zym
117058	ornithine decarboxylase	-	4.1.1.17
117058	oxidase	+
117058	phenylalanine ammonia-lyase	-	4.3.1.24
117058	protease	-
68382	trypsin	-	3.4.21.4	from API zym
117058	tryptophan deaminase	-
68377	tryptophan deaminase	-	4.1.99.1	from API NH
117058	tween esterase	-
117058	urease	+	3.5.1.5
68377	urease	+	3.5.1.5	from API NH
68369	urease	+	3.5.1.5	from API 20NE
68382	valine arylamidase	-		from API zym

API zym

@ref	Control	Alkaline phosphatase	Esterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	Lipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
117058	-	+	+	-	-	+	-	-	-	-	+	-	-	-	-	-	-	-	-	-

API 20NE

@ref	Reduction of nitratesNO3	TRP	GLU_ Ferm	ADH (Arg)	URE	ESC	GEL	PNPG	GLU_ Assim	ARA	MNE	MAN	NAG	MAL	GNT	CAP	ADI	MLT	CIT	PAC	OX
3892	+	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	+	+	+	+	+
3892	+	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	+	+	+	+	+
3892	+	-	+	-	+	-	-	-	-	-	-	-	-	-	-	-	+	+	+	+	+

API NH

@ref	PEN	GLU	FRU	MAL	SAC	ODC	URE	LIP	PAL	beta GAL	ProA	GGT	IND
3892	-	-	-	-	-	+	+	-	-	-	+	-	-
3892	-	-	-	-	-	-	+	+	-	-	-	+	-

API biotype100

@ref	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
117058	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-

Isolation, sampling and environmental information

Taxonmaps

69479

Global distribution of 16S sequence AJ278452 (>99% sequence identity) for Bordetella pertussis from Microbeatlas

Aquatic Samples	9586
Soil Samples	4730
Animal Samples	5464
Plant Samples	3383
Total Samples	23163

Interaction and safety

Risk assessment

@ref	Pathogenicity human	Pathogenicity animal	Biosafety level	Biosafety level comment
3892			2	Risk group (German classification) According to TRBA 466
117058			2	Risk group (French classification) According to TRBA 466

Sequence information

Genome sequences

@ref	Description	Assembly level	INSDC accession	BV-BRC accession	NCBI tax ID	Score
66792	54466_G01 assembly for Bordetella bronchiseptica NCTC8344	complete	GCA_900637995	518.72	518	99.68

16S sequences

@ref	Description	Accession	Length	Database	NCBI tax ID
3892	Bordetella bronchiseptica partial 16S rRNA gene, strain DSM 10303	AJ278452	1523		518

Genome-based predictions

Predictions

Predictions from Deep Learning for Genome Sequence Data. R package version 0.3.1 based on: Bordetella bronchiseptica strain NCTC8344
PATRIC: 518.72

@ref	Trait	Model	Prediction	Confidence in %	In training data
125439	spore_formation	BacteriaNetⓘ	no	96.60	no
125439	motility	BacteriaNetⓘ	yes	83.90	no
125439	gram_stain	BacteriaNetⓘ	negative	97.50	no
125439	oxygen_tolerance	BacteriaNetⓘ	obligate aerobe	96.90	no

Predictions from bacterial phenotypic traits through improved machine learning using high-quality, curated datasets based on: Bordetella bronchiseptica NCTC8344
NCBI: GCA_900637995.1

@ref	Trait	Model	Prediction	Confidence in %	In training data
125438	gram-positive	gram-positiveⓘ	no	96.48	no
125438	anaerobic	anaerobicⓘ	no	98.22	yes
125438	aerobic	aerobicⓘ	yes	86.63	yes
125438	spore-forming	spore-formingⓘ	no	89.01	no
125438	thermophilic	thermophileⓘ	no	97.07	no
125438	flagellated	motile2+ⓘ	yes	85.77	no

Literature

Topic	Title	Authors	Journal	DOI	Year
Metabolism	Elaboration of vomitoxin and zearalenone by Fusarium isolates and the biological activity of Fusarium-produced toxins.	Vesonder RF, Ellis JJ, Rohwedder WK.	Appl Environ Microbiol	10.1128/aem.42.6.1132-1134.1981	1981
Metabolism	Formation of extracellular C14-C18 2-D-hydroxy fatty acids by species of Saccharomycopsis.	Kurtzman CP, Vesonder RF, Smiley MJ.	Appl Microbiol	10.1128/am.26.4.650-652.1973	1973
Enzymology	Recommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchiseptica.	Pruller S, Fromke C, Kaspar H, Klein G, Kreienbrock L, Kehrenberg C.	PLoS One	10.1371/journal.pone.0123883	2015
	Investigation of the Correlation Between ELISA and Serum Amyloid A in the Diagnosis of Bordetella bronchiseptica in Dogs.	Akar K, Sanioglu Golen G, Ekin IH.	Vet Med Sci	10.1002/vms3.70323	2025
	Photo-catalytic and biological applications of phyto-functionalized zinc oxide nanoparticles synthesized using a polar extract of Equisetum diffusum D.	Assad N, Abbas A, Fayyaz Ur Rehman M, Naeem-Ul-Hassan M.	RSC Adv	10.1039/d4ra03573a	2024
	Development and Application of Fluorescent and Lateral Flow Dipstick Recombinase-Aided Amplification for Rapid Detection of Glaesserella parasuis	Che Y, Wang Y, Wu R, Wang L, Wu X, Chen Q, Chen R, Zhou L.	Vet Sci		2025
	Synthesis, Structural Properties and Biological Activities of Novel Hydrazones of 2-, 3-, 4-Iodobenzoic Acid.	Czyzewska I, Mazur L, Biernasiuk A, Hordyjewska A, Popiolek L.	Molecules	10.3390/molecules29163814	2024
	Bioactive, antioxidant and antimicrobial properties of chemically fingerprinted essential oils extracted from Eucalyptus globulus: in-vitro and in-silico investigations.	Nasir Shah S, Khan I, Tul Muntaha S, Hayat A, Ur Rehman M, Ali Shah T, Siddique F, Salamatullah AM, Mekonnen AB, Bourhia M.	Front Chem	10.3389/fchem.2023.1287317	2023
	Design, Synthesis, and In Vitro and In Vivo Bioactivity Studies of Hydrazide-Hydrazones of 2,4-Dihydroxybenzoic Acid.	Popiolek L, Gawronska-Grzywacz M, Dziduch A, Biernasiuk A, Piatkowska-Chmiel I, Herbet M.	Int J Mol Sci	10.3390/ijms242417481	2023
	Polyphenol Profile and Biological Activity of the Extracts from Sideritis scardica Griseb. (Lamiaceae) Herb	Walasek-Janusz M, Wojtanowski K, Paplinski R, Grzegorczyk A, Nurzynska-Wierdak R.	Pharmaceuticals (Basel)		2025
	Identification of Bordetella bronchiseptica in the throat and nose of dogs and cats by PCR.	Tabatabaei M, Rohani HR.	Mol Biol Res Commun	10.22099/mbrc.2022.43873.1755	2022
	Comparative HPLC-DAD-ESI-QTOF/MS/MS Analysis of Bioactive Phenolic Compounds Content in the Methanolic Extracts from Flowering Herbs of Monarda Species and Their Free Radical Scavenging and Antimicrobial Activities.	Kozyra M, Biernasiuk A, Wiktor M, Kukula-Koch W, Malm A.	Pharmaceutics	10.3390/pharmaceutics15030964	2023
	Effect of Commonly Used Cosmetic Preservatives on Healthy Human Skin Cells.	Glaz P, Rosinska A, Wozniak S, Boguszewska-Czubara A, Biernasiuk A, Matosiuk D.	Cells	10.3390/cells12071076	2023
	Chemical Composition, and Antioxidant and Antimicrobial Activity of Oregano Essential Oil.	Walasek-Janusz M, Grzegorczyk A, Malm A, Nurzynska-Wierdak R, Zalewski D.	Molecules	10.3390/molecules29020435	2024
	Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity.	Paruch K, Popiolek L, Biernasiuk A, Hordyjewska A, Malm A, Wujec M.	Molecules	10.3390/molecules25245844	2020
Enzymology	N-Substituted 2-(Benzenosulfonyl)-1-Carbotioamide Derivatives Exert Antimicrobial and Cytotoxic Effects via Aldehyde Dehydrogenase Pathway: Synthesis, In Silico and In Vitro Studies.	Walczak-Nowicka L, Biernasiuk A, Ziemichod W, Karczmarzyk Z, Kwasnik M, Kozyra P, Wysocki W, Stenzel-Bembenek A, Kowalczuk D, Herbet M, Pitucha M.	Pharmaceuticals (Basel)	10.3390/ph16121706	2023
	Structural and Biological Studies of Bioactive Silver(I) Complexes with Coumarin Acid Derivatives.	Wolska A, Drzewiecka-Antonik A, Barboza CA, Struga M, Stefanska J, Rejmak P, Klepka M.	Molecules	10.3390/molecules29214993	2024
	Synthesis, Spectral, Thermal and Biological Studies of 4-Cyclohexyl-3-(4-nitrophenyl)methyl-1,2,4-triazolin-5-thione and Its Copper(II) Coordination Compound, [CuCl₂(H₂O)₂L₂].	Czylkowska A, Drozd M, Biernasiuk A, Rogalewicz B, Malm A, Pitucha M.	Materials (Basel)	10.3390/ma13184135	2020
	Multidirectional Characterization of Phytochemical Profile and Health-Promoting Effects of Ziziphora bungeana Juz. Extracts.	Zhaparkulova K, Karaubayeva A, Sakipova Z, Biernasiuk A, Gawel-Beben K, Laskowski T, Kusniyeva A, Omargali A, Bekezhanova T, Ibragimova L, Ibadullayeva G, Jakiyanov A, Czech K, Tastambek K, Glowniak K, Malm A, Kukula-Koch W.	Molecules	10.3390/molecules27248994	2022
Phylogeny	Bioactivity-Directed Isolation of Anticancer Constituents from Underexplored Folklore: Rhus punjabensis Stewart.	Tabassum S, Ali JS, Saeed RF, Asghar M, Akhtar M, Ahmad AMR, Zia M.	Molecules	10.3390/molecules30224339	2025
	Synthesis and Physicochemical Characterization of Novel Dicyclopropyl-Thiazole Compounds as Nontoxic and Promising Antifungals.	Biernasiuk A, Banasiewicz A, Maslyk M, Martyna A, Janeczko M, Baranowska-Laczkowska A, Malm A, Laczkowski KZ.	Materials (Basel)	10.3390/ma14133500	2021
Pathogenicity	Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives.	Popiolek L, Biernasiuk A, Paruch K, Malm A, Wujec M.	Arch Pharm Res	10.1007/s12272-018-1025-3	2018
	Antioxidant and Antimicrobial Effects of Baby Leaves of Amaranthus tricolor L. Harvested as Vegetable in Correlation with Their Phytochemical Composition.	Sporna-Kucab A, Tekieli A, Kisiel A, Grzegorczyk A, Skalicka-Wozniak K, Starzak K, Wybraniec S.	Molecules	10.3390/molecules28031463	2023
	Chemical Composition, Biological Activity, and Potential Uses of Oregano (Origanum vulgare L.) and Oregano Essential Oil.	Nurzynska-Wierdak R, Walasek-Janusz M.	Pharmaceuticals (Basel)	10.3390/ph18020267	2025
	Carboxymethyl Cellulose/Gelatin Hydrogel Films Loaded with Zinc Oxide Nanoparticles for Sustainable Food Packaging Applications.	Zafar A, Khosa MK, Noor A, Qayyum S, Saif MJ.	Polymers (Basel)	10.3390/polym14235201	2022
	Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines.	Paruch K, Biernasiuk A, Berecka-Rycerz A, Hordyjewska A, Popiolek L.	Int J Mol Sci	10.3390/ijms222413669	2021
	The Phenolic Compounds Profile and Cosmeceutical Significance of Two Kazakh Species of Onions: Alliumgalanthum and A. turkestanicum.	Kadyrbayeva G, Zagorska J, Grzegorczyk A, Gawel-Beben K, Strzepek-Gomolka M, Ludwiczuk A, Czech K, Kumar M, Koch W, Malm A, Glowniak K, Sakipova Z, Kukula-Koch W.	Molecules	10.3390/molecules26185491	2021
	Development and application of two multiplex real-time PCR assays for detection and speciation of bacterial pathogens in the koala.	Hulse LS, Hickey D, Mitchell JM, Beagley KW, Ellis W, Johnston SD.	J Vet Diagn Invest	10.1177/1040638718770490	2018
	Synthesis, Biological Activity and Molecular Docking Studies of Novel Nicotinic Acid Derivatives.	Paruch K, Biernasiuk A, Khylyuk D, Paduch R, Wujec M, Popiolek L.	Int J Mol Sci	10.3390/ijms23052823	2022
	Betaxanthin Profiling in Relation to the Biological Activities of Red and Yellow Beta vulgaris L. Extracts.	Sporna-Kucab A, Tekieli A, Grzegorczyk A, Swiatek L, Boguszewska A, Skalicka-Wozniak K.	Metabolites	10.3390/metabo13030408	2023
	Synthesis and investigation of antimicrobial activities of nitrofurazone analogues containing hydrazide-hydrazone moiety.	Popiolek L, Biernasiuk A.	Saudi Pharm J	10.1016/j.jsps.2017.05.006	2017
	Bioactive molecules from haloarchaea: Scope and prospects for industrial and therapeutic applications.	Moopantakath J, Imchen M, Anju VT, Busi S, Dyavaiah M, Martinez-Espinosa RM, Kumavath R.	Front Microbiol	10.3389/fmicb.2023.1113540	2023
	Superior Antioxidant Capacity of Berberis iliensis-HPLC-Q-TOF-MS Based Phytochemical Studies and Spectrophotometric Determinations.	Abdykerimova S, Sakipova Z, Nakonieczna S, Koch W, Biernasiuk A, Grabarska A, Malm A, Kozhanova K, Kukula-Koch W.	Antioxidants (Basel)	10.3390/antiox9060504	2020
	Conserved Structural Features of Core Oligosaccharides among the Lipopolysaccharides of Respiratory Pathogens from the Genus Bordetella Analyzed Exclusively by NMR Spectroscopy.	Ucieklak K, Koj S, Niedziela T.	Int J Mol Sci	10.3390/ijms22031029	2021
	Novel functionalized beta-nitrostyrenes: Promising candidates for new antibacterial drugs.	Boguszewska-Czubara A, Kula K, Wnorowski A, Biernasiuk A, Popiolek L, Miodowski D, Demchuk OM, Jasinski R.	Saudi Pharm J	10.1016/j.jsps.2019.02.007	2019
	Ethnobotany, Phytochemistry, and Biological Activity of Extracts and Non-Volatile Compounds from Lantana camara L. and Semisynthetic Derivatives-An Updated Review.	Ramirez J, Armijos C, Espinosa-Ortega N, Castillo LN, Vidari G.	Molecules	10.3390/molecules30040851	2025
Metabolism	Bordetella holmesii Lipopolysaccharide Hide and Seek Game with Pertussis: Structural Analysis of the O-Specific Polysaccharide and the Core Oligosaccharide of the Type Strain ATCC 51541.	Ucieklak K, Koj S, Niedziela T.	Int J Mol Sci	10.3390/ijms21176433	2020
Metabolism	Development of a reverse transcription loop mediated isothermal amplification assay for the detection of Mouse reovirus type 3 in laboratory mice.	Lu T, Tao L, Yu H, Zhang H, Wu Y, Wu S, Zhou J.	Sci Rep	10.1038/s41598-021-83034-1	2021
	Herb Robert's Gift against Human Diseases: Anticancer and Antimicrobial Activity of Geranium robertianum L.	Swiatek L, Wasilewska I, Boguszewska A, Grzegorczyk A, Rezmer J, Rajtar B, Polz-Dacewicz M, Sieniawska E.	Pharmaceutics	10.3390/pharmaceutics15051561	2023
Pathogenicity	Assessment of phytochemicals, antimicrobial and cytotoxic activities of extract and fractions from Fagonia olivieri (Zygophyllaceae).	Rashid U, Khan MR, Jan S, Bokhari J, Shah NA.	BMC Complement Altern Med	10.1186/1472-6882-13-167	2013
	A Novel Strategy for the Separation of Functional Oils from Chamomile Seeds.	Milovanovic S, Grzegorczyk A, Swiatek L, Grzeda A, Debczak A, Tyskiewicz K, Konkol M.	Food Bioproc Tech	10.1007/s11947-023-03038-9	2023
	Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations.	Dafale NA, Semwal UP, Agarwal PK, Sharma P, Singh GN.	J Pharm Anal	10.1016/j.jpha.2014.07.007	2015
	One-Tube Nested Real-Time PCR Assay for Rapid Screening of Porcine Cytomegalovirus in Clinical Samples.	Wang HY, Song JK, Shin S, Choi KM, Kim H.	Front Vet Sci	10.3389/fvets.2020.586045	2020
	Rainbow Vectors for Broad-Range Bacterial Fluorescence Labeling.	Barbier M, Damron FH.	PLoS One	10.1371/journal.pone.0146827	2016
	Antioxidant, Antibacterial, and Cytotoxic Activities of the Ethanolic Origanum vulgare Extract and Its Major Constituents.	Coccimiglio J, Alipour M, Jiang ZH, Gottardo C, Suntres Z.	Oxid Med Cell Longev	10.1155/2016/1404505	2016
	Diversity of swine Bordetella bronchiseptica isolates evaluated by RAPD analysis and PFGE.	Shin EK, Seo YS, Han JH, Hahn TW.	J Vet Sci	10.4142/jvs.2007.8.1.65	2007
	Similarity analysis, synthesis, and bioassay of antibacterial cyclic peptidomimetics.	Berhanu WM, Ibrahim MA, Pillai GG, Oliferenko AA, Khelashvili L, Jabeen F, Mirza B, Ansari FL, Ul-Haq I, El-Feky SA, Katritzky AR.	Beilstein J Org Chem	10.3762/bjoc.8.128	2012
Pathogenicity	Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.	Hengzhuang W, Wu H, Ciofu O, Song Z, Hoiby N.	Antimicrob Agents Chemother	10.1128/aac.00126-11	2011
	An Insight into Fluorinated Imines and Hydrazones as Antibacterial Agents.	Sztanke M, Wilk A, Sztanke K.	Int J Mol Sci	10.3390/ijms25063341	2024
	Development of structurally extended benzosiloxaboroles - synthesis and in vitro biological evaluation.	Pacholak P, Krajewska J, Winska P, Dunikowska J, Gogowska U, Mierzejewska J, Durka K, Wozniak K, Laudy AE, Lulinski S.	RSC Adv	10.1039/d1ra04127d	2021
Pathogenicity	Isolation of antibacterial compounds from Quercus dilatata L. through bioassay guided fractionation.	Jamil M, ul Haq I, Mirza B, Qayyum M.	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-11-11	2012
	Exploiting thiol-functionalized benzosiloxaboroles for achieving diverse substitution patterns - synthesis, characterization and biological evaluation of promising antibacterial agents.	Nowicki K, Krajewska J, Stepniewski TM, Wielechowska M, Winska P, Kaczmarczyk A, Korpowska J, Selent J, Marek-Urban PH, Durka K, Wozniak K, Laudy AE, Lulinski S.	RSC Med Chem	10.1039/d4md00061g	2024
	Aromatic Diboronic Acids as Effective KPC/AmpC Inhibitors.	Krajewska J, Chyzy P, Durka K, Winska P, Krzysko KA, Lulinski S, Laudy AE.	Molecules	10.3390/molecules28217362	2023
	Partial purification and characterization of an antimicrobial activity from the wood extract of mangrove plant Ceriops decandra.	Simlai A, Mukherjee K, Mandal A, Bhattacharya K, Samanta A, Roy A.	EXCLI J	10.17179/excli2015-741	2016
	Phytochemical, in-vitro biological and chemo-preventive profiling of Arisaema jacquemontii Blume tuber extracts.	Tabassum S, Zia M, Carcahe de Blanco EJ, Batool R, Aslam R, Hussain S, Wali Q, Gulzar MM.	BMC Complement Altern Med	10.1186/s12906-019-2668-4	2019
	Synthesis, reactions and antimicrobial activities of 8-ethoxycoumarin derivatives.	Mohamed HM, Abd El-Wahab AH, Ahmed KA, El-Agrody AM, Bedair AH, Eid FA, Khafagy MM.	Molecules	10.3390/molecules17010971	2012
	Oxazoline scaffold in synthesis of benzosiloxaboroles and related ring-expanded heterocycles: diverse reactivity, structural peculiarities and antimicrobial activity.	Krajewska J, Nowicki K, Durka K, Marek-Urban PH, Winska P, Stepniewski T, Wozniak K, Laudy AE, Lulinski S.	RSC Adv	10.1039/d2ra03910a	2022
	Synthesis and preliminary evaluation of the antimicrobial activity of selected 3-benzofurancarboxylic acid derivatives.	Kossakowski J, Krawiecka M, Kuran B, Stefanska J, Wolska I.	Molecules	10.3390/molecules15074737	2010
	Disubstituted 4-Chloro-3-nitrophenylthiourea Derivatives: Antimicrobial and Cytotoxic Studies.	Bielenica A, Sanna G, Madeddu S, Giliberti G, Stefanska J, Koziol AE, Savchenko O, Strzyga-Lach P, Chrzanowska A, Kubiak-Tomaszewska G, Struga M.	Molecules	10.3390/molecules23102428	2018
	Synthesis, Structural Studies and Biological Evaluation of Connections of Thiosemicarbazide, 1,2,4-Triazole and 1,3,4-Thiadiazole with Palmitic Acid.	Jozwiak M, Stepien K, Wrzosek M, Olejarz W, Kubiak-Tomaszewska G, Filipowska A, Filipowski W, Struga M.	Molecules	10.3390/molecules23040822	2018
Pathogenicity	Synthesis and Biological Evaluation of Novel Indole-Derived Thioureas.	Sanna G, Madeddu S, Giliberti G, Piras S, Struga M, Wrzosek M, Kubiak-Tomaszewska G, Koziol AE, Savchenko O, Lis T, Stefanska J, Tomaszewski P, Skrzycki M, Szulczyk D.	Molecules	10.3390/molecules23102554	2018
Pathogenicity	1,4-Disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferation.	Dzitko K, Paneth A, Plech T, Pawelczyk J, Staczek P, Stefanska J, Paneth P.	Molecules	10.3390/molecules19079926	2014
	Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.	Arico B, Rappuoli R.	J Bacteriol	10.1128/jb.169.6.2847-2853.1987	1987
	Appraisal of phytochemical and in vitro biological attributes of an unexplored folklore: Rhus Punjabensis Stewart.	Tabassum S, Ahmed M, Mirza B, Naeem M, Zia M, Shanwari ZK, Khan GM.	BMC Complement Altern Med	10.1186/s12906-017-1659-6	2017
Pathogenicity	In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.	Hengzhuang W, Wu H, Ciofu O, Song Z, Hoiby N.	Antimicrob Agents Chemother	10.1128/aac.06486-11	2012
Pathogenicity	Demonstration of R factors in Bordetella bronchiseptica isolated from pigs.	Terakado N, Azechi H, Ninomiya K, Shimizu T.	Antimicrob Agents Chemother	10.1128/aac.3.5.555	1973
Enzymology	Validation of nested Bordetella PCR in pertussis vaccine trial.	Reizenstein E, Lindberg L, Mollby R, Hallander HO.	J Clin Microbiol	10.1128/jcm.34.4.810-815.1996	1996
Phylogeny	Differentiation of Bordetella avium and related species by cellular fatty acid analysis.	Moore CJ, Mawhinney H, Blackall PJ.	J Clin Microbiol	10.1128/jcm.25.6.1059-1062.1987	1987
Pathogenicity	Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.	Pachon-Ibanez ME, Docobo-Perez F, Lopez-Rojas R, Dominguez-Herrera J, Jimenez-Mejias ME, Garcia-Curiel A, Pichardo C, Jimenez L, Pachon J.	Antimicrob Agents Chemother	10.1128/aac.00367-09	2010
	Evolutionary trees for the genus Bordetella.	Altschul SF.	J Bacteriol	10.1128/jb.171.2.1211-1213.1989	1989
	Promoter of the pertussis toxin operon and production of pertussis toxin.	Nicosia A, Rappuoli R.	J Bacteriol	10.1128/jb.169.6.2843-2846.1987	1987
Pathogenicity	Design of antimicrobially active small amphiphilic peptide dendrimers.	Polcyn P, Jurczak M, Rajnisz A, Solecka J, Urbanczyk-Lipkowska Z.	Molecules	10.3390/molecules14103881	2009
	The international standard for colistin.	Lightbown JW, Bond JM, Grab B.	Bull World Health Organ		1973
	Microbioassay of antimicrobial agents.	Simon HJ, Yin EJ.	Appl Microbiol	10.1128/am.19.4.573-579.1970	1970
	Detection of Mycoplasma hyopneumoniae by using rRNA-oligodeoxynucleotide hybridization.	Futo S, Seto Y, Mitsuse S, Mori Y.	J Clin Microbiol	10.1128/jcm.30.6.1509-1513.1992	1992
	The international reference preparation of colistin methane sulfonate.	Lightbown JW, Bond JM, Grab B.	Bull World Health Organ		1973
	Selective filtration of antibiotics through collodion membranes.	Barza M, Bergeron MG, Brusch J, Weinstein L.	Antimicrob Agents Chemother	10.1128/aac.4.3.337	1973
	Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.	Curitis JR, Eastwood JB.	Br Med J	10.1136/bmj.1.5590.484	1968
	Stability of antibiotics and amino acids in two synthetic L-amino acid solutions commonly used for total parenteral nutrition in children.	Colding H, Andersen GE.	Antimicrob Agents Chemother	10.1128/aac.13.4.555	1978
Metabolism	Nucleic acid enzyme studies of nonfermentative gram-negative bacteria using thin-layer chromatography.	Klein MM, Blazevic DJ.	Appl Microbiol	10.1128/am.23.2.276-280.1972	1972
	Specific assay of aminoglycosidic- or polymyxin-type antibiotics present in human sera in combination with cephalosporins.	Stroy SA, Preston DA.	Appl Microbiol	10.1128/am.21.6.1002-1006.1971	1971
	Stability of antibiotics and chemotherapeutics in agar plates.	Ryan KJ, Needham GM, Dunsmoor CL, Sherris JC.	Appl Microbiol	10.1128/am.20.3.447-451.1970	1970
	Simplified, accurate method for antibiotic assay of clinical specimens.	Bennett JV, Brodie JL, Benner EJ, Kirby WM.	Appl Microbiol	10.1128/am.14.2.170-177.1966	1966
	Biological characterization of prasinomycin, a phosphorus-containing antibiotic.	Meyers E, Miraglia GJ, Smith DA, Basch HI, Pansy FE, Trejo WH, Donovick R.	Appl Microbiol	10.1128/am.16.4.603-608.1968	1968
Pathogenicity	Comparative study of the effect of three antibiotics on renal function.	Caldwell AD, Martin AJ, Trigger DJ.	Br J Pharmacol	10.1111/j.1476-5381.1969.tb09545.x	1969
	Sodium sulphomethyl derivatives of polymyxins.	Beveridge EG, Martin AJ.	Br J Pharmacol Chemother	10.1111/j.1476-5381.1967.tb01946.x	1967
	Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.	Robinson A, Irons LI.	Infect Immun	10.1128/iai.40.2.523-528.1983	1983
	Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction.	Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT.	J Clin Microbiol	10.1128/jcm.28.9.1982-1987.1990	1990
	Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.	Robinson A, Hawkins DC.	Infect Immun	10.1128/iai.39.2.590-598.1983	1983
	Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December 2019.	Merdrignac L, Ait El Belghiti F, Pandolfi E, Acosta L, Fabianova K, Habington A, Garcia Cenoz M, Boas H, Toubiana J, Tozzi AE, Jordan I, Zavadilova J, O'Sullivan N, Navascues A, Flem E, Croci I, Jane M, Krizova P, Cotter S, Fernandino L, Bekkevold T, Munoz-Almagro C, Bacci S, Kramarz P, Kissling E, Savulescu C, Renacoq Group, PERTINENT Group.	Vaccine	10.1016/j.vaccine.2024.02.090	2024
Pathogenicity	Synthesis, Characterization, Biological Evaluation and DNA Interaction Studies of 4-Aminophenol Derivatives: Theoretical and Experimental Approach.	Rafique B, Kalsoom S, Sajini AA, Ismail H, Iqbal M	Molecules	10.3390/molecules27041352	2022
	Occurence of Bordetella bronchiseptica in domestic cats with upper respiratory tract infections.	Garbal M, Adaszek L, Lyp P, Frymus J, Winiarczyk M, Winiarczyk S	Pol J Vet Sci	10.1515/pjvs-2016-0043	2016
Genetics	Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs.	Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL	J Clin Microbiol	10.1128/jcm.35.6.1550-1555.1997	1997
Enzymology	Residue determination of two co-administered antibacterial agents--cephalexin and colistin--in calf tissues using high-performance liquid chromatography and microbiological methods.	Leroy P, Decolin D, Nicolas S, Archimbault P, Nicolas A	J Pharm Biomed Anal	10.1016/0731-7085(89)80201-8	1989
Pathogenicity	Flow microcalorimetric assay of antibiotics--I. Polymyxin B sulphate and its combinations with neomycin sulphate and zinc bacitracin on interaction with Bordetella bronchiseptica (NCTC 8344).	Joslin Kjeldsen N, Beezer AE, Miles RJ	J Pharm Biomed Anal	10.1016/0731-7085(89)80005-6	1989

References

#3892	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 10303
#20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )
#34207	; Curators of the CIP;
#44557	Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 2514
#66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .
#68369	Automatically annotated from API 20NE .
#68377	Automatically annotated from API NH .
#68382	Automatically annotated from API zym .
#69479	João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .
#117058	Collection of Institut Pasteur ; Curators of the CIP; CIP 53.157
#125438	Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 )
#125439	Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 .
#126262	A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 )

Rate our new design

Content

About us

Bordetella bronchiseptica (CCUG 2514, NRRL B-140, DSM 10303)

Name and taxonomic classification

Morphology

Cell morphology

Colony morphology

Culture and growth conditions

Culture medium

Culture temp

Physiology and metabolism

Oxygen tolerance

Spore formation

Halophily

Metabolite utilization

Antibiotic resistance

Metabolite production

Metabolite tests

Enzymes

API zym

API 20NE

API NH

API biotype100

Isolation, sampling and environmental information

Taxonmaps

Interaction and safety

Risk assessment

Sequence information

Genome sequences

Genome browser: GCA_900637995

16S sequences

Genome-based predictions

Predictions

Literature

Literature

References

BacDive

Help

Social Media